-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $10 Price Target

Benzinga·05/26/2026 10:16:17
Listen to the news
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $10 price target.